logo

Incyte Corporation (INCY)



Trade INCY now with
  Date
  Headline
2/13/2020 7:09:06 AM Incyte Q4 GAAP EPS $0.51; Non-GAAP EPS $0.65
1/30/2020 6:16:32 AM Eli Lilly And Incyte Announce That Baricitinib Met Primary Endpoint In BREEZE-AD5
1/27/2020 6:46:23 AM Eli Lilly And Incyte: Baricitinib Met Primary Endpoint In BREEZE-AD4 Study
10/29/2019 7:13:38 AM Incyte Q3 EPS $0.59 Vs $0.14 Last Year
10/8/2019 6:47:00 AM Lilly To Present New Data For Taltz, Olumiant And Mirikizumab At 28th Annual EADV Congress
9/27/2019 8:22:03 AM Incyte Announces Positive Updated Results From Phase 2 Trial Of Pemigatinib
9/25/2019 7:43:36 AM Incyte Says First Patient Treated In Phase 3 Clinical Trial Program Of Ruxolitinib Cream In Patients With Vitiligo
9/25/2019 7:38:04 AM Incyte Says First Patient Treated In Phase 3 Clinical Trial Program On Ruxolitinib Cream
  
 
>